© 2021 Marker Therapeutics, Inc.
TapImmune Inc., Jacksonville’s publicly traded developer of cancer-fighting immunotherapies, announced in May that it was merging with Minnesota-based Marker Therapeutics Inc., another developer of immunotherapies.
Company developing immunotherapy treatments for cancer up 139 percent this year.